Efung Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 15


  • Investments
  • 105

  • Portfolio
  • 68

  • Exits
  • 22


Efung Capital General Information

Company Description

Founded in 2007, Efung Capital is a venture capital firm based in Shenzhen, China. The firm seeks to invest in the healthcare and life science sectors.

Business Details

Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • Unit 5, 5th Floor, 2666 Ke Yuan Nan Road
  • China Resources Tower
  • Shenzhen, Nanshan
  • China
+86 0755 0000 0000

Efung Capital Investments (105)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ordinaire 20-Sep-2023 Later Stage VC Medical Supplies Generating Revenue 000 000
Pregis New Materials 04-Sep-2023 00000 00000 000.00 Computers, Parts and Peripherals Generating Revenue
Sunho Biologics 02-Aug-2023 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2
LingyiMed 05-May-2023 00000 00000 000.00 BPO/Outsource Services Generating Revenue 000 000
Asia Regenerative Medicine 08-Feb-2023 00000 00000 Laboratory Services (Healthcare) Pre-Clinical Trials 0000000 000
Chinabridge Medical Group 07-Feb-2023 00000 00000 Therapeutic Devices Generating Revenue
IASO Bio 15-Jan-2023 00000 00000 000.00 Drug Discovery Clinical Trials - General
Raynovent Biotech 04-Jan-2023 00000 00000 000.00 Drug Discovery Generating Revenue 0000000 000
Genocury 03-Jan-2023 Early Stage VC Drug Discovery Generating Revenue 000-0000 0000
Mygene 29-Dec-2022 Later Stage VC Biotechnology Generating Revenue
You’re viewing 10 of 105 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Efung Capital Exits (22)

Company Name Exit Date Exit Type Exit Size
Elicio Therapeutics 01-Jun-2023 Reverse Merger
3D Medicines 15-Dec-2022 000 00000
Apexigen 01-Aug-2022 0000000 000000
OBiO Technology 22-Mar-2022 000 00000
Asieris Pharmaceuticals 07-Jan-2022 000 00000
Harbour BioMed 10-Dec-2020 000 00000
Frontier Biotechnologies 28-Oct-2020 000 00000
Quaero Life Science 20-Jul-2020 000000000 00000000 00.000
Qyuns 10-Jun-2020 Secondary Transaction - Private 00.000
Lifotronic 05-Nov-2019 IPO 000.00
You’re viewing 10 of 22 exits. Get the full list »

Efung Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Efung Capital Management, Team & Partners (17)

Name Title Deals Funds Boards Office
Jinqiao Zhu Co-Founder, Chairman and President 0 0 Shenzhen, China
Pai Zhu Managing Partner 0 0 Shenzhen, China
Ruina Wang Partner 0 Shenzhen, China
Cheng Cui Investment Team Member Shenzhen, China
Hao Li Investment Team Member Shenzhen, China
You’re viewing 5 of 17 team members. Get the full list »

Efung Capital Co-Investors (181)

Name With Exits Lead Partner Series Industry
Kaitai Capital 4 Series chart Industry bar
Gaorong Capital 0 0 Series chart Industry bar
HongShan 0 0 0 Series chart Industry bar
Shenzhen Gaoxin Investment 0 0 Series chart Industry bar
Yantai Guofeng Investment 0 Series chart Industry bar
You’re viewing 5 of 181 co-investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »